MRL Ventures Fund
Profile, fund size and portfolio
MRL Ventures Fund is the corporate venture arm of Merck, a pharmaceutical and biotech company. It was founded in 2014 and is based in Cambridge, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Biotech and life sciences |
| Geography | North America, Europe, Asia |
| Offices | Cambridge, United States |
Sources: S1 MRL Ventures Fund.
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Active | 13 | 86.7% |
| Exited | 2 | 13.3% |
Status as the firm tags it
Sources: S1 MRL Ventures Fund.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 500M | Commitment by parent | Stated by the firm or its parent | S1 |
| Companies backed | 15 | companies | Stated by the firm | S1 |
| Exits | 2+ | exits | Stated by the firm | S1 |
| Companies on the firm's portfolio page | 15 | companies | Counted from the firm's own list | S1 |
Sources: S1 MRL Ventures Fund.
Where it invests and who leads it
LeadersS1
- Peter DudekPresident and Managing PartnerFind on LinkedInFirm page
- Karin KleinhansPartnerFind on LinkedInFirm page
- Olga DanilchankaPartnerFind on LinkedInFirm page
- Tao FangSenior AssociateFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Merck | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Founded | 2014 | Single source | S1 |
| Headquarters | Cambridge, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | USD 500M (Commitment by parent) | Single source | S1 |
| Companies backed | 15 | Single source | S1 |
| Exits | 2+ total | Single source | S1 |
| Stages | Seed, Series A | Single source | S1 |
For founders
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
Portfolio
The firm's portfolio page lists 15 companies: 13 active, 2 exited.S1
| Tag | Companies | Share |
|---|---|---|
| Active | 13 | 86.7% |
| Exited | 2 | 13.3% |
Every company on the MRL Ventures Fund list
15 companies, as listed on the firm's own website: 13 active, 2 exited.S1 Read the firm's list.
Active 13
- ADRx
- Ambagon Therapeutics
- Anavo Therapeutics
- Atb Therapeutics
- Axonis
- HotSpot Therapeutics
- Indupro
- Insamo
- LifeMine
- Mozart Therapeutics
- Ray Therapeutics
- Tallac Therapeutics
- VectorY Therapeutics
Exited 2
- Aktis Oncology
- Carisma Therapeutics
Official pages
Read the firm's own pages for current information.
- Website www.msd.com/research/business-development-and-licensing/mrl-ventures-fund/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by MRL Ventures Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.